Skip to content

Team Craik

£12.00

FXG Advanced Viroblock Face Mask -Team Craik

Support the 2020 Scottish Junior Champions and World Junior Bronze medalists by buying their very own custom face mask. The mask is white and features the Tream Craik logo in blue and grey.

For every sale we will give the team £5 and help to fund their 2021 Season.

Using the very latest fabric treatment from leading Swiss technology brand HEIQ our mask will give added confidence to prevent the spread of any virus.

This 3-part mask is engineered for performance, tailored for comfort, and using advanced Viroblock treatment for maximum protection. Each mask is supplied with 2 removeable filters.

Detail and specification:

Standard mask size: Adult: 20cm x 15cm (8 inches x 6 inches)

Elasticated straps for comfort with plastic toggles for adjustment.

Fabric composition:   Outer Fabric: 94%polyester fibre, 6% spandex, Inner Fabric:  Polyamide / Polypropylene mix

Latex-free

Washing: For best results wash in warm or hot water (at least 40°C/104°F).

Relive some famous games from world curling with this special edition face covering.

Please visit our dedicated face mask website to see our full collection.

www.fxg-masks.co.uk

 

* These masks are not medical devices or personal protective equipment (PPE). They are for personal use and are not intended for use by health care professionals or for use in hospitals or health care facilities. These face masks should not be used in any surgical setting or where significant exposure to liquid, bodily or other hazardous fluids may be expected, a clinical setting where the infection risk level through inhalation exposure is high, the presence of a high intensity heat source or flammable gas.

** There are seven types of human coronavirus: 229E and COVID-19 are two of them. The different types of coronaviruses are highly similar in their membrane structure. The membrane is what our vesicle and silver technology in HeiQ Viroblock NPJ03 targets in order to achieve reduction in the viruses’ infectivity. Our technology has also been tested against Influenza types H1N1, H5N1, H7N9, and Respiratory Syncytial Virus (RSV) and demonstrated significantly improved reduction of virus infectivity. Regarding the efficacy of our technology on COVID-19, a direct test has not yet been carried out.

Description

Effective in minutes, the features of Virolblock NPJ03 include:

Strong antiviral and antibacterial effect against enveloped viruses and bacteria

HeiQ Viroblock NPJ03 has proven effective against human coronavirus (229E) in face mask testing

Washing: Lasts at least 30 gentle washes at 40°C/104°F

Residual virus infectivity tested according to a modified ISO 20743 method (Sendai), rapid antiviral effect demonstrated within 2-5 minutes

Hypoallergenic, provides self-sanitizing and germ resistant surface

Patent pending antiviral and antibacterial technology

EU BPR & EU REACH compliant, main ingredient registered with US TSCA and US EPA

Detail and specification:

Standard mask size: Adult: 20cm x 15cm (8 inches x 6 inches)

Elasticated straps for comfort with plastic toggles for adjustment.

Fabric composition:   Outer Fabric: 94%polyester fibre, 6% spandex, Inner Fabric:  Polyamide / Polypropylene mix

Latex-free

Washing: For best results wash in warm or hot water (at least 40°C/104°F).

* These masks are not medical devices or personal protective equipment (PPE). They are for personal use and are not intended for use by health care professionals or for use in hospitals or health care facilities. These face masks should not be used in any surgical setting or where significant exposure to liquid, bodily or other hazardous fluids may be expected, a clinical setting where the infection risk level through inhalation exposure is high, the presence of a high intensity heat source or flammable gas.

** There are seven types of human coronavirus: 229E and COVID-19 are two of them. The different types of coronaviruses are highly similar in their membrane structure. The membrane is what our vesicle and silver technology in HeiQ Viroblock NPJ03 targets in order to achieve reduction in the viruses’ infectivity. Our technology has also been tested against Influenza types H1N1, H5N1, H7N9, and Respiratory Syncytial Virus (RSV) and demonstrated significantly improved reduction of virus infectivity. Regarding the efficacy of our technology on COVID-19, a direct test has not yet been carried out.

Additional information

Weight .25 kg
Back To Top